Form 8-K - Current report:
SEC Accession No. 0000950170-24-068311
Filing Date
2024-06-04
Accepted
2024-06-04 08:28:23
Documents
25
Period of Report
2024-06-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K neog-20240604.htm   iXBRL 8-K 38773
2 EX-99.1 neog-ex99_1.htm EX-99.1 15355
3 GRAPHIC neog-ex99_1s1.jpg GRAPHIC 634809
4 GRAPHIC neog-ex99_1s2.jpg GRAPHIC 703591
5 GRAPHIC neog-ex99_1s3.jpg GRAPHIC 380529
6 GRAPHIC neog-ex99_1s4.jpg GRAPHIC 404455
7 GRAPHIC neog-ex99_1s5.jpg GRAPHIC 537922
8 GRAPHIC neog-ex99_1s6.jpg GRAPHIC 338659
9 GRAPHIC neog-ex99_1s7.jpg GRAPHIC 532969
10 GRAPHIC neog-ex99_1s8.jpg GRAPHIC 485303
11 GRAPHIC neog-ex99_1s9.jpg GRAPHIC 409790
12 GRAPHIC neog-ex99_1s10.jpg GRAPHIC 359372
13 GRAPHIC neog-ex99_1s11.jpg GRAPHIC 411345
14 GRAPHIC neog-ex99_1s12.jpg GRAPHIC 228024
15 GRAPHIC neog-ex99_1s13.jpg GRAPHIC 385010
  Complete submission text file 0000950170-24-068311.txt   8177790

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20240604.xsd EX-101.SCH 25022
28 EXTRACTED XBRL INSTANCE DOCUMENT neog-20240604_htm.xml XML 4730
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 241016145
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)